Catalyst Wire Dossier Catalyst Wire Dossier

Moderna COVID-19 vaccine (mRNA-1273)

mRNA-1273 · Moderna, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Moderna COVID-19 vaccine (mRNA-1273), covering 2024-08-27 to 2024-08-27. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy [Phase 2]

See pricing